Purdue Pharma L.P.
Case Number:
7:19-bk-23649
Court:
Nature of Suit:
Firms
- Akin Gump
- Alston & Bird
- Andrews & Thornton
- ArentFox Schiff
- Arnold & Porter
- ASK LLP
- Ballard Spahr
- Barack Ferrazzano
- BatesCarey
- Bentley & Bruning
- Bialson Bergen
- Bielli & Klauder
- Binder & Schwartz
- Blank Rome
- Blitman & King
- Brown & Connery
- Brown Rudnick
- Caplin & Drysdale
- Carter Ledyard
- Cleary Gottlieb
- Clifford Law Offices
- Consovoy McCarthy
- Cozen O'Connor
- Cronin Fried
- Crowell & Moring
- Cuneo Gilbert
- Davis Polk
- Debevoise & Plimpton
- Dechert LLP
- Doster Ullom
- Duane Morris
- Faegre Drinker
- Foley & Lardner
- FrankGecker
- Frost Brown
- Gage Spencer & Fleming
- Gertz & Rosen
- Gilbert LLP
- Godfrey & Kahn
- Goodwin Procter
- Hagens Berman
- Haug Partners
- Henrichsen Law Group
- Himes Petrarca
- Hobbs Straus
- Hughes Socol
- Hurwitz Fine
- Ifrah Law
- Jenner & Block
- Jones Day
- Joseph Hage Aaronson
- Katsky Korins
- Keller Postman
- Keller Rohrback
- King & Spalding
- Kirkland & Ellis
- Klehr Harrison
- Kleinberg Kaplan
- Kobre & Kim
- Kramer Levin
- Latham & Watkins
- Law Office of Nhan Nguyen
- Lerner Arnold
- Levenfeld Pearlstein
- Lite DePalma
- Locke Lord
- Loeb & Loeb
- Lowe Stein
- Lowey Dannenberg
- MacElree Harvey
- Marcus & Shapira
- Marino Tortorella
- Mayer Brown
- McElroy Deutsch
- McGrail & Bensinger
- Mehri & Skalet
- Miller Nash LLP
- Miller Shah LLP
- Mintz Levin
- MoloLamken
- Morgan Lewis
- Motley Rice
- Napoli Shkolnik
- O'Brien Belland
- O'Melveny & Myers
- Pachulski Stang
- Phillips Lytle
- Pillsbury Winthrop
- Porteous Hainkel
- Porter Hedges
- Porzio Bromberg
- Potter Anderson
- Pullman & Comley
- Reed Smith
- Robins Kaplan
- Rothstein Mandell
- Saul Ewing
- Schulte Roth
- Seward & Kissel
- Shafferman & Feldman
- Sherrard Roe
- Shipman & Goodwin
- Shook Hardy
- Simpson Thacher & Bartlett LLP
- Skadden Arps
- Slevin & Hart
- Spangenberg Shibley
- Squire Patton
- Stevens & Lee
- Stutzman Bromberg
- Taft Stettinius
- Tarter Krinsky
- Tate Law Group LLC
- Teitelbaum Law Group
- Terrell Hogan
- The Cooper Law Firm
- UB Greensfelder
- Wachtell Lipton
- Waldrep Wall
- White & Case
- White Coleman & Associates
- Wilk Auslander
- Williams Mullen
- Willkie Farr
- WilmerHale
Companies
- Alaska Native Tribal Health Consortium
- Aleutian Pribilof Islands Association Inc.
- Allergan PLC
- American Federation of Labor & Congress of Industrial Organizations
- Amneal Pharmaceuticals Inc.
- Anda Inc.
- Apria Healthcare Group
- Arcadia Consumer Healthcare
- ASM Capital LP
- Avrio Health LP
- AXA XL Ltd.
- Bausch Health Cos. Inc.
- Blue Cross Blue Shield Association
- Bristol-Myers Squibb Co.
- Cardinal Health Inc.
- Cencora Inc.
- Collegium Pharmaceutical Inc.
- CVS Health Corp.
- DuPont de Nemours Inc.
- Endo International PLC
- Express Scripts Holding Co.
- Giant Eagle Inc.
- Hain Capital Group LLC
- Henry Schein Inc.
- Hikma Pharmaceuticals PLC
- Houlihan Lokey Inc.
- Impax Laboratories, Inc.
- International Union Of Operating Engineers
- Ironshore Inc.
- Jefferies Financial Group Inc.
- Johnson & Johnson
- Kodiak Area Native Association
- KVK Tech Inc.
- Liberty Mutual Insurance Group
- Loblaw Cos.
- McKesson Corp.
- Noramco Inc.
- Old Republic Insurance Co.
- Omnicare Inc.
- Oracle Corp.
- PRA Health Sciences Inc.
- Province LLC
- Purdue Pharma LP
- Ranbaxy
- SAP AG
- Sun Pharmaceutical Industries Ltd.
- Teamsters Local 456
- Teva Pharmaceutical Industries Ltd.
- The Cigna Group
- Thermo Fisher Scientific Inc.
- TR Capital Management LLC
- Tucson Medical Center
- United Food & Commercial Workers International Union
- United Parcel Service Inc.
- Viatris Inc.
- Walmart Inc.
Government Agencies
- Borough of Paramus, New Jersey
- City of Bayonne, New Jersey
- Commonwealth of Massachusetts
- Hopi Tribe
- Jamestown S'Klallam Tribe
- Missouri Department of Revenue
- New York Department of Financial Services
- Nez Perce Tribe
- Northwestern Band of the Shoshone Nation
- Pala Band of Mission Indians
- Pension Benefit Guaranty Corp.
- Port Gamble S'Klallam Tribe
- Seldovia Village Tribe
- State of Indiana
- State of Nevada
- St. Regis Mohawk Tribe
- Suquamish Tribe
- Tennessee Attorney General's Office
- Town of Babylon, New York
- Town of Brookhaven, New York
- Town of Hempstead, New York
- Town of Ramapo, New York
- Washington State Department of Revenue
Sectors & Industries:
-
August 18, 2021
Ex-Purdue Chair Denies Blame For Opioid Crisis
A former president and board chairman of Purdue Pharma on Wednesday denied that the company or its owners in the Sackler family bore responsibility for the United States' opioid crisis as the confirmation hearing for Purdue's Chapter 11 plan entered its fifth day.
-
August 17, 2021
Sacklers Say They'll Fight Any Attempt To Foil Ch. 11 Releases
A member of the Purdue Pharma-owning Sackler family told a New York bankruptcy judge Tuesday that his family will not settle opioid claims without the releases in the company's proposed Chapter 11 plan and promised protracted fights against attempts to seek damages outside of bankruptcy.
-
August 16, 2021
Sackler Reps Say They Can't Sell Assets Without Releases
The liability releases for Purdue Pharma-owning members of the Sackler family in its Chapter 11 plan must stand in order for a court in the British Crown dependency of Jersey to release assets needed to fund the $4.5 billion settlement at its center, family representatives told a New York bankruptcy court Monday.
-
August 13, 2021
Sacklers' Ch. 11 Releases Are Fair, Supporting States Say
States and other government bodies that consented to Purdue Pharma's Chapter 11 plan defended the plan's liability releases for members of the Sackler family as the confirmation trial entered its second day Friday, arguing that it's a fair deal to fund opioid abatement.
-
August 12, 2021
Purdue's Ch. 11 Trial Opens With Attacks On Sackler Releases
States took immediate aim at Purdue Pharma's Chapter 11 plan letting members of the Sackler family off the hook for liability, asking at the two-week confirmation trial that kicked off in New York bankruptcy court Thursday if the company had looked at all the alternatives.
-
August 09, 2021
Purdue Allotted 10 Days For Ch. 11 Confirmation Trial
OxyContin maker Purdue Pharma's Chapter 11 plan confirmation trial will be limited to 10 days, after a New York bankruptcy judge said Monday that objectors to the plan had requested far too much time to cross-examine the debtor's fact and expert witnesses.
-
August 06, 2021
Purdue Pharma Says Sackler Releases Are Vital To Ch. 11 Plan
Bankrupt OxyContin maker Purdue Pharma LP is asking a New York bankruptcy judge to approve its Chapter 11 plan as it defends its $4.5 billion settlement with members of the Sackler family as necessary for the plan to work.
-
July 29, 2021
Purdue Pharma Gets OK For $22M Worker Bonus Program
A New York bankruptcy judge Thursday gave Purdue Pharma the go-ahead to pay up to $22.1 million in retention bonuses to midlevel workers, rejecting calls to delay the decision until after next month's Chapter 11 plan confirmation hearing.
-
July 27, 2021
Purdue Pharma Reports Glowing Vote Results For Ch. 11 Plan
Bankrupt OxyContin maker Purdue Pharma said Tuesday it had achieved widespread support among voting creditors for its Chapter 11 plan, saying more than 95% of the 120,000 votes submitted are in favor of its proposal.
-
July 20, 2021
Examiner Clears Sacklers Of Influencing Purdue's Board
An examiner appointed in the Chapter 11 case of drugmaker Purdue Pharma LP told a New York bankruptcy court late Monday that the company's board acted independently of the Sackler family when it proposed a $4.5 billion settlement with the owners that forms the basis of its bankruptcy plan.